Nachrichten zur Moderna Aktie

Moderna stock extends losses as investors digest melanoma vaccine trial data

Moderna shares ended Friday’s session modestly lower, extending the sharp losses recorded in the previous trading sessions.…

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful result for melanoma patients who underwent…

Moderna trims losses as investors digest melanoma vaccine trial data

Moderna stock stabilized on Friday, reversing the prior sessions steep sell-off.…

Stocks making the biggest moves premarket: AT&T, SpaceX, Moderna, Deckers, Bloom Energy and more

These are the stocks posting the largest moves in early trading.…

25 Prozent im Minus: Krebs-Impfstoff erfolgreich - Moderna-Aktie bricht trotzdem ein

Eine groß angelegte Patientenstudie bestätigt das hohe Potenzial personalisierter Immuntherapien gegen Hautkrebs. Trotz der überzeugenden Studienergebnisse beim Melanom gerät die Aktie…

Moderna stock’s 17% slump was a ‘sell the news’ event, analyst says

Moderna shares tumbled after leaked cancer vaccine trial data showed promising results for its treatment developed with Merck.…

Moderna plunges on leaked vaccine data, Musk to invest $1B in Skydance, Spotify surges

Market Domination Host Brooke DiPalma tracks several of the days top trending stock tickers, including Moderna (MRNA) plunging after the…

Pharma: Krebsimpfstoff-Daten von Moderna und Merck vorzeitig veröffentlicht – Aktien fallen

Vorzeitig bekannt gewordene Studiendaten zu einem Krebsimpfstoff setzen Moderna und Merck & Co. unter Druck. Zeitweise verlor die Moderna-Aktie bis…

Moderna shares plunge after leak of cancer vaccine data despite positive results

Modernas stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of…

Moderna shares plunge on apparent cancer vaccine data leak

Moderna shares plunge on apparent cancer vaccine data leak…

Moderna (MRNA) Rises Higher Than Market: Key Facts

The latest trading day saw Moderna (MRNA) settling at $245.81, representing a +1.54% change from its previous close.…

Why is Moderna stock rallying today?

Why is Moderna stock rallying today?…

Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline

BioNTech has billions in cash, and its oncology programs are moving into late-stage clinical trials.…

Moderna stock sinks as Wall Street turns cautious following blistering rally

Moderna sank as Wall Street grew more cautious on the companys valuation after a massive rally this year.…

MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?

Moderna gains $4.2 billion in a week on cancer-vaccine optimism and Nasdaq-100 inclusion. Can its growth prospects justify its premium…

Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just…

Moderna: Momentum-Bulle steigt auf ein Mehrjahreshoch - Das skizzierte Trendfollowing-Szenario entfaltet seine Wirkung!

Über Moderna (MRNA) habe ich zuletzt am 17. September an dieser Stelle berichtet. Seither ist die Aktie von 160 auf…

Tempus AI Expands Strategic Collaborations to Drive Future Growth

TEM is expanding its precision medicine footprint through strategic collaborations with Moderna, Merck and Recursion, paving the way for future…

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

…

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

Moderna stock is up 663% in 2026, beating AI names for the S&P 500 lead. Full cancer vaccine data arrives…

Why Moderna Stock Surged Today

The biotech could play a significant role in a national effort to combat cancer.…

This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street

Have Moderna’s shares risen too much, too fast?…

Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up

Modernas NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index…

Arbutus Biopharma: $230M Buyback And Moderna Cash De-Risk The Path To A Potential HBV Cure

…

Stocks making the biggest moves midday: Marvell, Moderna, Lamb Weston, Constellation Energy & more

Here are some of the companies making headlines in midday trading.…

Moderna: Aktie vor erneuter Verdopplung?

Nach dem Corona-Boom kämpfte Moderna mit sinkenden Umsätzen. Jetzt sorgen neue Präparate, Kostensenkungen und Fortschritte beim personalisierten Krebsimpfstoff für Rückenwind.…

Moderna to join Nasdaq 100, replacing Warner Bros Discovery

Nasdaq said ?on Thursday that Moderna ?will join the Nasdaq-100 Index, replacing Warner Bros. ?Discovery , ?on October 9.…

Moderna (MRNA) Stock Dips While Market Gains: Key Facts

Moderna (MRNA) closed the most recent trading day at $188.94, moving 1.89% from the previous trading session.…

Stocks making big moves yesterday: United Therapeutics, Moderna, Jabil, Concentrix, and FactSet

Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.…

Moderna Aktie nach 222%-Rally: Citi sagt jetzt "sell" - Kursziel steigt trotzdem

Bad Marienberg (www.aktiencheck.de) - Nach einer spektakulären Rally der Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

These are the stocks posting the largest moves midday.…

Citi delivers major verdict after Moderna’s remarkable 703% run

Moderna’s rally has priced in unrealistic expectations for its cancer drug sales.…

Prediction: Moderna Stock Will Soar 100% by 2030

The company could enter a fresh growth phase.…

Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?

MRNAs respiratory vaccine expansion and promising oncology results offer potential growth as COVID-19 demand normalizes.…

Stocks making the biggest moves premarket: Robinhood, Boeing, Moderna & more

These are the stocks posting the largest moves premarket.…

Premarket movers: Micron; Boeing rises, Moderna slides

Premarket movers: Micron; Boeing rises, Moderna slides…

Moderna has been on a tear since mid-August. Citi now sees it plunging 60%

Analyst Geoff Meacham downgraded the biotech name to sell.…

4 Winning Single-Stock Leveraged ETF Areas of First Nine Months of 2026

Moderna, Micron, Intel and AMD have powered huge gains in single-stock leveraged ETFs in 2026. Here are four standout areas.…

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing

Moderna (MRNA) concluded the recent trading session at $198.88, signifying a +2.08% move from its prior days close.…

Moderna: Die irre Rally geht weiter – AKTIONÄR-Depotwert +257% seit Mitte Mai

Mit einem Plus von knapp sieben Prozent gehörte die Aktie von Moderna am Donnerstag erneut zu den Outperformern im S&P…

3 Bullish Setups for the Week Ahead

As the bulls reassert their power, leading stocks like SanDisk, Coinbase, and Moderna are setting up in constructive base structures.…

3 Bullish Setups for the Week Ahead

As the bulls reassert their power, leading stocks like SanDisk, Coinbase, and Moderna are setting up in constructive base structures.…

Axsome Therapeutics vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?

One company is growing a commercial drug business with limited margin for error on the path to profitability. The other…

Zacks Investment Ideas feature highlights: NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver

NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver have been highlighted in this Investment…

dpa-AFX ProFeed